top of page

About Us

Upper Bio-tech Co., Ltd. (NEEQ: 873758), based in Zhangjiang Science City Modern Medical Device Park and London Bioscience Innovation Centre, is committed to becoming a global innovator in research and intelligent Point-of-Care Testing (iPOCT).

Core Competencies:
Key Focus Areas:
  • 20+ national/provincial-level key research projects
  • 400+ intellectual property portfolio (patents/utility models/software copyrights)
  • 5 national/industry/group standards participation
  • 7 scientific awards and 10+ honors including National Key New Products
  • Three R&D platforms: Postdoctoral Research Station, Shanghai Engineering Research Center for POCT, and Municipal Enterprise Technology Center

Specializing in rapid quantitative diagnostics for cardiovascular diseases, diabetic nephropathy, autoimmune disorders, reproductive health, infectious diseases and inflammatory conditions. Our 60+ instruments and reagents serve 10M+ patients annually through 1,000+ domestic and international healthcare institutions.

Industry Leadership:
  • Authored three seminal monographs: POCT, iPOCT and IVD+Big Data Smart Diagnosis
  • Pioneered the iPOCT framework emphasizing Precision, Automation, Cloud-connectivity and Sharing
  • Developed "Smart Diagnostics + Health Big Data" ecosystem
  • Implemented groundbreaking "3D Innovation" strategy integrating Instruments, Reagents and AI-powered Quality Control
Capital Markets:

As an NEEQ Innovation Tier listed company, we synergize Free Trade Zone policies with the biopharma cluster advantages. Through our "Capital-Technology-Market" tripartite strategy, we are advancing toward becoming an international leading digital diagnostics enterprise.

Milestone

1997–2011

2012–2015

2017–2023

2024–2025

Established
Focused Expertise
Strengthening Independent Innovation
Rapid Growth

Established in 1997 in Shanghai. Focused on POCT and designed early semi‑automatic quantitative immunochromatographic analyzers.

Specialized in the field of inflammation and infection testing. Launched advanced POCT systems and expanded into key clinical application areas.

Achieved multiple national‑level honors and certifications for innovation and excellence. Built integrated platforms for instruments, reagents and data.

Accelerated product pipeline and market expansion. Developed platforms for assembly‑line testing, kidney and cardiac disease detection, and fully automated testing systems.

Core Strengths

01 Talent Reserve

  • 1,227+ employees across optics, mechanics, electronics, software and biomedicine
  • 100+ R&D staff, including PhD‑level experts and senior clinical specialists

02 R&D Strength

  • R&D investment consistently above 20% of annual revenue
  • Led and participated in multiple national and provincial key R&D projects
  • Strong track record in translating research into high-value IVD products

03 Intellectual Property & Recognition

  • 280+ intellectual property rights (patents, utility models and software copyrights)
  • Recognized as a National Intellectual Property Demonstration Enterprise

Clinical Focus Areas

Kidney Diseases

mALB, CRE, UTRF, RBP, α1‑M, β2‑M, NAG, ACR, eGFR, HbA1c

Inflammatory & Infectious Diseases

SAA, CRP, PCT, HBP, IL‑6 and other key markers

Cardiovascular & Cerebrovascular Diseases

proBNP, cTn‑T, CK‑MB, Myo, H‑FABP, D‑dimer, ST2

Core In‑House Technologies

rengong.png
Artificial Enzyme Catalysis Platform

Fully synthetic enzyme technology providing high stability, high sensitivity and strong anti‑interference performance for iPOCT assays.

guangshi.png
Broad‑Spectrum Marker Detection

Multiplex detection platform covering key inflammatory and infectious disease biomarkers, enabling rapid, quantitative and multi‑parameter testing.

faguang.png
Fluorescent Immunoassay Platform

High‑throughput, high‑precision fluorescent immunoassay system designed for critical care and emergency testing scenarios.

LAMP.png
LAMP Rapid Molecular Detection

Isothermal amplification technology for fast, accurate nucleic acid detection at the point of care, reducing turnaround time for clinical decisions.

图片n.png
Integrated Optical Detection Platform

LED‑based optical system integrating excitation, detection and analysis in one compact module, supporting a wide range of IVD applications.

bottom of page